Is RVMD up or down today?
RVMD is up 0.17% today, last at 207.68. This stock moved +0.17% versus the prior close.
RVMD · RVMD
RVMD (RVMD) is trading at 207.68, up 0.17% on the session. RVMD sits at the 91% mark of its 52-week range, carries a 14-day RSI of 53, and trades above its 50-day average. Over the past month it is up 0.34%.
Leading the coverage: “Revolution Medicines(RVMD.US) Director Sells US$11.38 Million in Common Stock - Moomoo” (Google News Company, 7d ago). RVMD is -0.74% since story.
RVMD trades on a trailing P/E of 18.0 and is running 1.72% ahead of the S&P 500 over the same stretch.
Analyst firms are mostly reiterating — no strong directional shift lately.
RVMD is up 0.17% today, last at 207.68. This stock moved +0.17% versus the prior close.
Leading the coverage: “Revolution Medicines(RVMD.US) Director Sells US$11.38 Million in Common Stock - Moomoo” (Google News Company, 7d ago). RVMD is -0.74% since story. Dominant story: Morgan Stanley Initiates Coverage on Revolution Medicines With Overweight Rating (2 sources, neutral) RSI is 53 — neutral Price above 50-day average — short-term uptrend Social sentiment loads separately — see the Social tab.
Analyst firms are mostly reiterating — no strong directional shift lately.
Loaded: Mar 2026 – Sep 2026 (124 days) · Drag or scroll left for earlier dates
Morgan Stanley Initiates Coverage on Revolution Medicines With Overweight Rating
Morgan Stanley initiates Revolution stock with overweight on Rasonque approval - Investing.com
RVMD Maintained by Stifel -- Price Target Raised to $230 - GuruFocus
Stifel Maintains Buy on Revolution Medicines, Raises Price Target to $230
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib (Revolution Medicines’ RASONQUE™) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial